United States Science News API

{
    "totalArticles": 51978,
    "articles": [
        {
            "id": "28e9699377541c46168a0a9f2c70a968",
            "title": "NASA Says Goodbye to its Longtime Mars MAVEN Mission",
            "description": "The space agency announced that the MAVEN spacecraft, which has circled Mars for more than a decade, is being decommissioned.",
            "content": "On Wednesday, NASA announced the end of a more than 11-year mission aimed at solving a key mystery about Mars: What happened to the air that once made the planet habitable?\nThe NASA spacecraft MAVEN, short for Mars Atmosphere and Volatile Evolution, ... [1434 chars]",
            "url": "https://www.nytimes.com/2026/06/03/science/nasa-maven-mars-orbiter.html",
            "image": "https://static01.nyt.com/images/2026/06/09/multimedia/03SCI-NASA-MAVEN-kgmq/03SCI-NASA-MAVEN-kgmq-facebookJumbo.jpg",
            "publishedAt": "2026-06-04T01:29:28Z",
            "lang": "en",
            "source": {
                "id": "2f580dc49292a1caf59cd86dd3c9e60b",
                "name": "The New York Times",
                "url": "https://www.nytimes.com"
            }
        },
        {
            "id": "c151ca93df1d6ff1210f0fe20571c8cd",
            "title": "Towards mRNA therapeutics 2.0",
            "description": "mRNA technology, which has enabled the rapid development of vaccines for infectious diseases, also holds great promise for a new generation of therapies for a host of rare and common diseases. A decade of clinical trials are beginning to clarify the key barriers to unlock the transformative potential of mRNA drugs, which are being addressed with novel interdisciplinary technical advances that, in some cases, are integrating the fields of gene, cell and mRNA therapies. Here, we review the scientific insights from a select group of clinical studies on mRNA-based drugs, including enzyme replacement therapies for rare diseases, cancer immunotherapies, genome-modifying therapies, and immune cell reprogramming therapies for cancer and autoimmune diseases. Several innovative approaches such as clinically tractable in vivo delivery systems, the development of completely ‘immune-silent’ mRNA–vehicle formulations that allow repeated administration and the development of approaches for preferential delivery to organs other than the liver would expedite the development of mRNA therapeutics 2.0. mRNA technology is being applied to develop a new generation of therapies for rare and common diseases. This Review discusses insights from clinical studies on mRNA-based therapeutics, including enzyme replacement therapies, cancer immunotherapies, genome-modifying therapies and immune cell reprogramming therapies, which illustrate how technological advances are paving the way for the wider adoption of mRNA technology in drug development.",
            "content": "Kallen, K.-J. et al. A novel, disruptive vaccination technology: self-adjuvanted RNActive® vaccines. Hum. Vaccin. Immunother. 9, 2263–2276 (2013).\nBaden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–... [43833 chars]",
            "url": "https://www.nature.com/articles/s41573-026-01459-7?error=cookies_not_supported&code=5cad6b14-21bc-4c60-819e-6d5e431e0574",
            "image": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-026-01459-7/MediaObjects/41573_2026_1459_Fig1_HTML.png",
            "publishedAt": "2026-06-03T20:07:04Z",
            "lang": "en",
            "source": {
                "id": "7abf0df285fbe93cdccffcc7c4088737",
                "name": "Nature",
                "url": "https://www.nature.com"
            }
        },
        {
            "id": "87fd803a645d686c1a0e002efe51d01d",
            "title": "Like 'the loss of a loved one': NASA's Mars orbiter MAVEN is officially dead after months of radio silence",
            "description": "NASA has declared its MAVEN Mars orbiter dead after Red Planet anomaly led to months of lost contact.",
            "content": "NASA is saying goodbye to one of its most accomplished Mars orbiters.\nAfter months of repeated attempts to reestablish contact with the Mars Atmosphere and Volatile EvolutioN (MAVEN) satellite, NASA has declared the Red Planet probe dead. MAVEN's las... [2994 chars]",
            "url": "https://www.space.com/space-exploration/launches-spacecraft/nasas-maven-mars-orbiter-is-officially-dead-after-months-of-radio-silence",
            "image": "https://cdn.mos.cms.futurecdn.net/28oCLxYZR7P9vjnUXG6fUH-720-80.png",
            "publishedAt": "2026-06-03T19:50:09Z",
            "lang": "en",
            "source": {
                "id": "024dd4370bda9e6e6791231c2a935d20",
                "name": "Space",
                "url": "https://www.space.com"
            }
        }
    ]
}